Monday, April 13, 2009

Mymetics Corporation Completes Important Acquisition

Released Thursday April 9, 2009, 11:38 am EDT

NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (http://www.mymetics.com) Corporation (OTC BB:MYMX.OB - News) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM.L - News) as per the terms of the LOI described in the form 8-k filed on March 5, 2009.
The Mymetics Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5478
Safe Harbor Forward-Looking Statements? Statements contained in this release that are not strictly historical are ``forward-looking statements''. Such forward-looking statements are sometimes identified by words such as ``intends'', ``anticipates'', ``believes'', ``expects'' and ``hopes''. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
Contact:
Mymetics Corporation
North America
Anthony Jessop,
Senior Vice President
1 303 800 6606
anthony.jessop@mymetics.com
Switzerland
Mr. Ernest Luebke,
Chief Financial Officer
41 22 363 1310
Ernest.luebke@mymetics.ch

Visit www.emergingmarketsllc.com for full disclaimer

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:


Disclaimer: EMC has a August 20th,2008 with SIDC SA to provide various IR services on behalf of MYMX MyMetics. The terms of this agreement provide that EMC be paid 100,000 free trading shares for 30 days worth of services. To date EMC has received 300,000 shares.

No comments:

Post a Comment